ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
- Citation:
- Blood vol 118 (26) 6920-6929
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 1
- Parents:
- 467
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, P50 CA140158, CA140158, CA16058, CA101140, U10 CA077658, CA41287, U10 CA031946, R21 CA129657, U10 CA033601, U24 CA114725, U10 CA101140, U10 CA041287, P30 CA016058, CA77658, CA129657, CA114725, CA31946
- Corr. Author:
- Authors:
- Klaus H. Metzeler Heiko Becker Kati Maharry Michael D. Radmacher Jessica Kohlschmidt Krzysztof Mrózek Deedra Nicolet Susan P. Whitman Yue-Zhong Wu Sebastian Schwind Bayard L. Powell Thomas H. Carter Meir Wetzler Joseph O. Moore Jonathan E. Kolitz Maria R. Baer Andrew J. Carroll Richard A. Larson Michael A. Caligiuri Guido Marcucci Clara D. Bloomfield
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-20202, CALGB-8461, CALGB-9665
- Phases:
- N/A
- Keywords:
- Clinical Trials and Observations, Myeloid Neoplasia